* This is the Professional Version. *
Peptic Ulcer Disease
A peptic ulcer is an erosion in a segment of the GI mucosa, typically in the stomach (gastric ulcer) or the first few centimeters of the duodenum (duodenal ulcer), that penetrates through the muscularis mucosae. Nearly all ulcers are caused by Helicobacter pylori infection or NSAID use. Symptoms typically include burning epigastric pain that is often relieved by food. Diagnosis is by endoscopy and testing for H. pylori. Treatment involves acid suppression, eradication of H. pylori (if present), and avoidance of NSAIDs.
Ulcers may range in size from several millimeters to several centimeters. Ulcers are delineated from erosions by the depth of penetration; erosions are more superficial and do not involve the muscularis mucosae. Ulcers can occur at any age, including infancy and childhood, but are most common among middle-aged adults.
H. pylori and NSAIDs disrupt normal mucosal defense and repair, making the mucosa more susceptible to acid. H. pylori infection (see Helicobacter pylori Infection) is present in 50 to 70% of patients with duodenal ulcers and 30 to 50% of patients with gastric ulcers. If H. pylori is eradicated, only 10% of patients have recurrence of peptic ulcer disease, compared with 70% recurrence in patients treated with acid suppression alone. NSAIDs now account for > 50% of peptic ulcers.
Cigarette smoking is a risk factor for the development of ulcers and their complications. Also, smoking impairs ulcer healing and increases the incidence of recurrence. Risk correlates with the number of cigarettes smoked per day. Although alcohol is a strong promoter of acid secretion, no definitive data link moderate amounts of alcohol to the development or delayed healing of ulcers. Very few patients have hypersecretion of gastrin (Zollinger-Ellison syndrome—see Gastrinoma).
A family history exists in 50 to 60% of children with duodenal ulcer.
Symptoms depend on ulcer location and patient age; many patients, particularly elderly patients, have few or no symptoms. Pain is most common, often localized to the epigastrium and relieved by food or antacids. The pain is described as burning or gnawing, or sometimes as a sensation of hunger. The course is usually chronic and recurrent. Only about half of patients present with the characteristic pattern of symptoms.
Gastric ulcer symptoms often do not follow a consistent pattern (eg, eating sometimes exacerbates rather than relieves pain). This is especially true for pyloric channel ulcers, which are often associated with symptoms of obstruction (eg, bloating, nausea, vomiting) caused by edema and scarring.
Duodenal ulcers tend to cause more consistent pain. Pain is absent when the patient awakens but appears in mid-morning, is relieved by food, but recurs 2 to 3 h after a meal. Pain that awakens a patient at night is common and is highly suggestive of duodenal ulcer. In neonates, perforation and hemorrhage may be the first manifestation of duodenal ulcer. Hemorrhage may also be the first recognized sign in later infancy and early childhood, although repeated vomiting or evidence of abdominal pain may be a clue.
Diagnosis of peptic ulcer is suggested by patient history and confirmed by endoscopy. Empiric therapy is often begun without definitive diagnosis. However, endoscopy allows for biopsy or cytologic brushing of gastric and esophageal lesions to distinguish between simple ulceration and ulcerating stomach cancer. Stomach cancer may manifest with similar manifestations and must be excluded, especially in patients who are > 45, have lost weight, or report severe or refractory symptoms. The incidence of malignant duodenal ulcer is extremely low, so biopsies of lesions in that area are generally not warranted. Endoscopy can also be used to definitively diagnose H. pyloriinfection, which should be sought when an ulcer is detected (see Helicobacter pylori Infection : Diagnosis).
Gastrin-secreting cancer and Zollinger-Ellison syndrome should be considered when there are multiple ulcers, when ulcers develop in atypical locations (eg, postbulbar) or are refractory to treatment, or when the patient has prominent diarrhea or weight loss. Serum gastrin levels should be measured in these patients.
Mild to severe hemorrhage is the most common complication of peptic ulcer disease. Symptoms include hematemesis (vomiting of fresh blood or “coffee ground” material); passage of bloody stools (hematochezia) or black tarry stools (melena); and weakness, orthostasis, syncope, thirst, and sweating caused by blood loss.
A peptic ulcer may penetrate the wall of the stomach. If adhesions prevent leakage into the peritoneal cavity, free penetration is avoided and confined perforation occurs. Still, the ulcer may penetrate into the duodenum and enter the adjacent confined space (lesser sac) or another organ (eg, pancreas, liver). Pain may be intense, persistent, referred to sites other than the abdomen (usually the back when caused by penetration of a posterior duodenal ulcer into the pancreas), and modified by body position. CT or MRI is usually needed to confirm the diagnosis. When therapy does not result in healing, surgery is required.
Ulcers that perforate into the peritoneal cavity unchecked by adhesions are usually located in the anterior wall of the duodenum or, less commonly, in the stomach. The patient presents with an acute abdomen. There is sudden, intense, continuous epigastric pain that spreads rapidly throughout the abdomen, often becoming prominent in the right lower quadrant and at times referred to one or both shoulders. The patient usually lies still because even deep breathing worsens the pain. Palpation of the abdomen is painful, rebound tenderness is prominent, abdominal muscles are rigid (boardlike), and bowel sounds are diminished or absent. Shock may ensue, heralded by increased pulse rate and decreased BP and urine output. Symptoms may be less striking in elderly or moribund patients and those receiving corticosteroids or immunosuppressants.
Diagnosis is confirmed if an x‑ray or CT shows free air under the diaphragm or in the peritoneal cavity. Upright views of the chest and abdomen are preferred. The most sensitive view is the lateral x‑ray of the chest. Severely ill patients may be unable to sit upright and should have a lateral decubitus x‑ray of the abdomen. Failure to detect free air does not exclude the diagnosis.
Immediate surgery is required. The longer the delay, the poorer is the prognosis. IV antibiotics effective against intestinal flora (eg, cefotetan, or amikacin plus clindamycin) should be given. Usually, an NGT is inserted to do continuous nasogastric suction. In the rare cases when surgery cannot be done, prognosis is poor.
Obstruction may be caused by scarring, spasm, or inflammation from an ulcer. Symptoms include recurrent, large-volume vomiting, occurring more frequently at the end of the day and often as late as 6 h after the last meal. Loss of appetite with persistent bloating or fullness after eating also suggests gastric outlet obstruction. Prolonged vomiting may cause weight loss, dehydration, and alkalosis.
If the patient’s history suggests obstruction, physical examination, gastric aspiration, or x-rays may provide evidence of retained gastric contents. A succussion splash heard > 6 h after a meal or aspiration of fluid or food residue > 200 mL after an overnight fast suggests gastric retention. If gastric aspiration shows marked retention, the stomach should be emptied and endoscopy done or x-rays taken to determine site, cause, and degree of obstruction.
Edema or spasm caused by an active pyloric channel ulcer is treated with gastric decompression by nasogastric suction and acid suppression (eg, IV H2 blockers). Dehydration and electrolyte imbalances resulting from protracted vomiting or continued nasogastric suctioning should be vigorously sought and corrected. Prokinetic agents are not indicated. Generally, obstruction resolves within 2 to 5 days of treatment. Prolonged obstruction may result from peptic scarring and may respond to endoscopic pyloric balloon dilation. Surgery is necessary to relieve obstruction in selected cases.
Factors that affect recurrence of ulcer include failure to eradicate H. pylori, continued NSAID use, and smoking. Less commonly, a gastrinoma (Zollinger-Ellison syndrome) may be the cause. The 3-yr recurrence rate for gastric and duodenal ulcers is < 10% when H. pylori is successfully eradicated but > 50% when it is not. Thus, a patient with recurrent disease should be tested for H. pylori and treated again if the tests are positive.
Although long-term treatment with H2blockers, proton pump inhibitors, or misoprostol reduces the risk of recurrence, their routine use for this purpose is not recommended. However, patients who require NSAIDs after having had a peptic ulcer are candidates for long-term therapy, as are those with a marginal ulcer or prior perforation or bleeding.
Treatment of gastric and duodenal ulcers requires eradication of H. pylori when present (see Helicobacter pylori Infection : Treatment; see also the Cochrane review abstract: Antibiotics for people with peptic ulcers caused by Helicobacter pylori infection ) and a reduction of gastric acidity. For duodenal ulcers, it is particularly important to suppress nocturnal acid secretion.
Methods of decreasing acidity include a number of drugs, all of which are effective but which vary in cost, duration of therapy, and convenience of dosing. In addition, mucosal protective drugs (eg, sucralfate) and acid-reducing surgical procedures may be used. Drug therapy is discussed elsewhere (see Drug Treatment of Gastric Acidity).
With current drug therapy, the number of patients requiring surgery has declined dramatically. Indications include perforation, obstruction, uncontrolled or recurrent bleeding, and, although rare, symptoms that do not respond to drug therapy.
Surgery consists of a procedure to reduce acid secretion, often combined with a procedure to ensure gastric drainage. The recommended operation for duodenal ulcer is highly selective, or parietal cell, vagotomy (which is limited to nerves at the gastric body and spares antral innervation, thereby obviating the need for a drainage procedure). This procedure has a very low mortality rate and avoids the morbidity associated with resection and traditional vagotomy. Other acid-reducing surgical procedures include antrectomy, hemigastrectomy, partial gastrectomy, and subtotal gastrectomy (ie, resection of 30 to 90% of the distal stomach). These are typically combined with truncal vagotomy. Patients who undergo a resective procedure or who have an obstruction require gastric drainage via a gastroduodenostomy (Billroth I) or gastrojejunostomy (Billroth II).
The incidence and type of postsurgical symptoms vary with the type of operation. After resective surgery, up to 30% of patients have significant symptoms, including weight loss, maldigestion, anemia, dumping syndrome, reactive hypoglycemia, bilious vomiting, mechanical problems, and ulcer recurrence.
Weight loss is common after subtotal gastrectomy; the patient may limit food intake because of early satiety (because the residual gastric pouch is small) or to prevent dumping syndrome and other postprandial syndromes. With a small gastric pouch, distention or discomfort may occur after a meal of even moderate size; patients should be encouraged to eat smaller and more frequent meals.
Maldigestion and steatorrhea caused by pancreaticobiliary bypass, especially with Billroth II anastomosis, may contribute to weight loss.
Anemia is common (usually from iron deficiency, but occasionally from vitamin B12 deficiency caused by loss of intrinsic factor or bacterial overgrowth) in the afferent limb, and osteomalacia may occur. IM vitamin B12 supplementation is recommended for all patients with total gastrectomy but may also be given to patients with subtotal gastrectomy if deficiency is suspected.
Dumping syndrome may follow gastric surgical procedures, particularly resections. Weakness, dizziness, sweating, nausea, vomiting, and palpitation occur soon after eating, especially hyperosmolar foods. This phenomenon is referred to as early dumping, the cause of which remains unclear but likely involves autonomic reflexes, intravascular volume contraction, and release of vasoactive peptides from the small intestine. Dietary modifications, with smaller, more frequent meals and decreased carbohydrate intake, usually help.
Reactive hypoglycemia or late dumping (another form of the syndrome) results from rapid emptying of carbohydrates from the gastric pouch. Early high peaks in blood glucose stimulate excess release of insulin , which leads to symptomatic hypoglycemia several hours after the meal. A high-protein, low-carbohydrate diet and adequate caloric intake (in frequent small feedings) are recommended.
Mechanical problems (including gastroparesis and bezoar formation—see Bezoars) may occur secondary to a decrease in phase III gastric motor contractions, which are altered after antrectomy and vagotomy. Diarrhea is especially common after vagotomy, even without a resection (pyloroplasty).
Ulcer recurrence, according to older studies, occurs in 5 to 12% after highly selective vagotomy and in 2 to 5% after resective surgery. Recurrent ulcers are diagnosed by endoscopy and generally respond to either proton pump inhibitors or H2 blockers. For ulcers that continue to recur, the completeness of vagotomy should be tested by gastric analysis, H. pylori should be eliminated if present, and Zollinger-Ellison syndrome should be ruled out by serum gastrin studies.
Peptic ulcers affect the stomach or duodenum and can occur at any age, including infancy and childhood.
Most ulcers are caused by H. pylori infection or NSAID use; both factors disrupt normal mucosal defense and repair, making the mucosa more susceptible to acid.
Burning pain is common; food may worsen gastric ulcer symptoms but relieve duodenal ulcer symptoms.
Acute complications include GI bleeding and perforation; chronic complications include gastric outlet obstruction, recurrence, and, when H. pylori infection is the cause, stomach cancer.
Diagnose with endoscopy and do tests for H. pylori infection.
Give acid-suppressing drugs and therapy to eradicate H. pylori.
Drug NameSelect Trade
amikacinNo US brand name
* This is the Professional Version. *